These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4041065)

  • 1. Narcotic antagonist potentiation of apomorphine drug effect: a stereospecific, centrally mediated drug action.
    Quock RM; Kouchich FJ; Fries DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):239-43. PubMed ID: 4041065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM
    Life Sci; 1982 Dec; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of apomorphine-induced climbing in mice by reversible and irreversible narcotic antagonist drugs.
    Quock RM; Lucas TS
    Life Sci; 1981 Mar; 28(12):1421-4. PubMed ID: 7242242
    [No Abstract]   [Full Text] [Related]  

  • 7. Microwave facilitation of domperidone antagonism of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Kouchich FJ; Ishii TK; Lange DG
    Bioelectromagnetics; 1987; 8(1):45-55. PubMed ID: 3579999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade by naloxone of cocaine-induced hyperactivity, reverse tolerance and conditioned place preference in mice.
    Kim HS; Park WK; Jang CG; Oh KW; Kong JY; Oh S; Rheu HM; Cho DH; Kang SY
    Behav Brain Res; 1997 Apr; 85(1):37-46. PubMed ID: 9095340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of apomorphine-induced gnawing in mice.
    Hedley LR; Wallach MB
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):47-56. PubMed ID: 6682986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of choline and narcotic antagonists upon apomorphine discrimination.
    Schechter MD
    Eur J Pharmacol; 1980 Nov; 68(2):187-91. PubMed ID: 7202485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: studies using mu-opioid receptor gene knockout mice.
    Jang C; Park Y; Tanaka S; Ma T; Loh HH; Ho IK
    Brain Res Mol Brain Res; 2000 May; 78(1-2):204-6. PubMed ID: 10891603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of apomorphine-induced rotational behaviour by naloxone.
    Quock RM; Welsh TB
    J Pharm Pharmacol; 1981 Feb; 33(2):111-3. PubMed ID: 6111591
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 15. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
    Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone and naltrexone on drug-induced hypothermia in mice.
    Weiss J; Thompson ML; Shuster L
    Neuropharmacology; 1984 May; 23(5):483-9. PubMed ID: 6738824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate antagonists reverse the hypoactivity associated with systemic anaphylaxis in mice.
    Amir S
    Pharmacol Biochem Behav; 1984 Mar; 20(3):483-5. PubMed ID: 6709679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy.
    Namba MM; Quock RM; Malone MH
    Proc West Pharmacol Soc; 1980; 23():285-9. PubMed ID: 7190698
    [No Abstract]   [Full Text] [Related]  

  • 19. Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
    Verebey K; Kogan MJ; Mulè SJ
    Psychopharmacology (Berl); 1981; 75(1):44-7. PubMed ID: 6795658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.